India to Indonesia: Ritonavir Export Trade Route
India has recorded 26 verified shipments of Ritonavir exported to Indonesia, representing a combined trade value of $26.6M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $1.0M USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 90% of total export value with 4 shipments worth $24.0M USD. On the buying side, THE ORDER OF is the largest importer in Indonesia with $24.0M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD , HETERO LABS LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Indonesia Ritonavir corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $26.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 90% of all export value, reflecting the consolidated nature of India's ritonavir manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $1.0M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with ritonavir's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 29.8%, placing it at rank #9 among India's top ritonavir export destinations globally.
On the import side, key buyers of Indian ritonavir in Indonesia include THE ORDER OF, SAMPHARINDO RETROVIRAL INDONESIA , TO THE ORDER and 9 others. THE ORDER OF is the single largest importer with 1 shipments valued at $24.0M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ4
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#9
- Annual growth+29.8%
- Demand growth+24.9%
- Regulatory ease76/100
Top 10 Indian Ritonavir Exporters to Indonesia
Showing top 10 of 7 Indian suppliers exporting Ritonavir to Indonesia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED Avg $6.0M per shipment | 4 | $24.0M | 90.4% |
| 2 | MACLEODS PHARMACEUTICALS LTD Avg $107.3K per shipment | 14 | $1.5M | 5.6% |
| 3 | HETERO LABS LIMITED Avg $274.5K per shipment | 2 | $549.0K | 2.1% |
| 4 | LAURUS LABS LTD Avg $237.5K per shipment | 1 | $237.5K | 0.9% |
| 5 | MACLEODS PHARMACEUTICALS LTD Avg $50.3K per shipment | 3 | $150.8K | 0.6% |
| 6 | HETERO LABS LIMITED Avg $124.8K per shipment | 1 | $124.8K | 0.5% |
| 7 | EMCURE PHARMACEUTICALS LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting ritonavir to Indonesia, ranked by total trade value. The listed exporters are: MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD , HETERO LABS LIMITED, LAURUS LABS LTD, MACLEODS PHARMACEUTICALS LTD, HETERO LABS LIMITED, EMCURE PHARMACEUTICALS LIMITED. MYLAN LABORATORIES LIMITED is the dominant supplier with 4 shipments worth $24.0M USD, giving it a 90% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Ritonavir Importers in Indonesia
Showing top 10 of 12 known buyers in Indonesia receiving Ritonavir shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ritonavir in Indonesia include THE ORDER OF, SAMPHARINDO RETROVIRAL INDONESIA , TO THE ORDER, Sampharindo Retroviral Indonesia SRI, TO THE ORDER , among 12 total buyers. The largest importer is THE ORDER OF, accounting for $24.0M USD across 1 shipments — representing 90% of all ritonavir imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | THE ORDER OF | 1 | $24.0M | 90.2% |
| 2 | SAMPHARINDO RETROVIRAL INDONESIA | 14 | $1.5M | 5.6% |
| 3 | TO THE ORDER | 1 | $359.1K | 1.3% |
| 4 | Sampharindo Retroviral Indonesia SRI | 1 | $237.5K | 0.9% |
| 5 | TO THE ORDER | 1 | $189.9K | 0.7% |
| 6 | TO THE ORDER OF | 1 | $124.8K | 0.5% |
| 7 | PT SAMPHARINDO RETROVIRAL INDONESIA | 2 | $102.3K | 0.4% |
| 8 | SAMPHARINDO RETROVIRAL INDONESIA | 1 | $48.5K | 0.2% |
| 9 | XXSOLXXIONXXPOLXXERBXXN 1X | 1 | $16.5K | 0.1% |
| 10 | XXSolXXionXXPolXXerbXXn 1X | 1 | $16.4K | 0.1% |
Showing top 10 of 12 Ritonavir importers in Indonesia on this route.
Top 10 Ritonavir Formulations Imported by Indonesia
Showing top 10 of 18 product formulations shipped on the India to Indonesia Ritonavir route, ranked by trade value
Indonesia imports a wide range of ritonavir formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120S) (10000 PACKS X 120S = 1200000 NOS) — accounts for $24.0M USD across 1 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120S) (10000 PACKS X 120S = 1200000 NOS) | 1 | $24.0M | 90.2% |
| 2 | LOPINAVIR AND RITONAVIR TABLETS 200 50 M | 6 | $552.9K | 2.1% |
| 3 | RITOCOM RITONAVIR + LOPINAVIR TABLET ALONG WITH FREE SAMPLE:32 CON 3840 TABLET | 1 | $359.1K | 1.3% |
| 4 | LOPINAVIR AND RITONAVIR TABLETS 200+50MG | 2 | $276.9K | 1.0% |
| 5 | LOPINAVIR AND RITONAVIR TABLETS 200+50 M | 2 | $274.0K | 1.0% |
| 6 | LOPINAVIR AND RITONAVIR TABLETS 200 50MG | 1 | $237.5K | 0.9% |
| 7 | RITOCOM RITONAVIR + LOPINAVIR TABLET | 1 | $189.9K | 0.7% |
| 8 | LOPINAVIR AND RITONAVIR TABLETS 200/50 M | 1 | $158.5K | 0.6% |
| 9 | LOPI NAVIR RITONAVIR W/W TAB25KG POU ID | 1 | $124.8K | 0.5% |
| 10 | LOPINAVIR 200MG AND RITONAVIR 50 MG TABL | 1 | $117.7K | 0.4% |
Showing top 10 of 18 Ritonavir formulations imported by Indonesia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 17 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's ritonavir exports to Indonesia are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Indonesia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD , HETERO LABS LIMITED — together account for 98% of total trade value on this route. The average shipment value of $1.0M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lopinavir and ritonavir tablets 200 50 m and ritocom ritonavir + lopinavir tablet along with free sample:32 con 3840 tablet, suggesting that buyers in Indonesia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, THE ORDER OF is the largest importer with 1 shipments worth $24.0M USD — representing 90% of all ritonavir imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $26.6M
- Avg. Shipment
- $1.0M
- Suppliers
- 7
- Buyers
- 12
- Transit (Sea)
- ~17 days
- Annual Growth
- +29.8%
Other Ritonavir Routes
Unlock the Full India to Indonesia Ritonavir Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — India to Indonesia Ritonavir Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ritonavir to Indonesia?
The leading Indian exporters of Ritonavir to Indonesia are MYLAN LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD , HETERO LABS LIMITED. MYLAN LABORATORIES LIMITED holds the largest market share at approximately 90% of total trade value on this route.
Q What is the total value of Ritonavir exports from India to Indonesia?
India exports Ritonavir to Indonesia worth approximately $26.6M USD across 26 recorded shipments. The average value per shipment is $1.0M USD.
Q Which ports does India use to ship Ritonavir to Indonesia?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 17 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Indonesia for Ritonavir?
The average transit time for Ritonavir shipments from India to Indonesia is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Indonesia Ritonavir trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.8% with demand growth tracking at 24.9%. The route is ranked #9 among India's top Ritonavir export destinations globally.
Q How many suppliers are active on the India to Indonesia Ritonavir route?
There are currently 7 active Indian suppliers exporting Ritonavir to Indonesia. The market is moderately concentrated with MYLAN LABORATORIES LIMITED accounting for 90% of total shipment value.
Q Who are the main importers of Ritonavir from India in Indonesia?
The leading importers of Indian Ritonavir in Indonesia include THE ORDER OF, SAMPHARINDO RETROVIRAL INDONESIA , TO THE ORDER, Sampharindo Retroviral Indonesia SRI, TO THE ORDER . THE ORDER OF is the largest buyer with 1 shipments worth $24.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Indonesia export trade corridor identified from Indian Customs (DGFT) records for Ritonavir.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 12 importers in Indonesia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists